Dynamic Cell Therapies develops controllable CAR T cells for the treatment of cancers.
Dynamic Cell Therapies has raised $1.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2024.
Dynamic Cell Therapies's investors include Myeloma Investment Fund.
Dynamic Cell Therapies is headquartered in Watertown, United States.
Dynamic Cell Therapies develops controllable CAR T cells for the treatment of cancers.
Dynamic Cell Therapies is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Dynamic Cell Therapies — Funding & Investors." VCBacked, July 11, 2024, https://www.vcbacked.co/company/dynamic-cell-therapies. Accessed August 14, 2026.
VCBacked. (2024). Dynamic Cell Therapies — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/dynamic-cell-therapies
{{cite web |title=Dynamic Cell Therapies — Funding & Investors |url=https://www.vcbacked.co/company/dynamic-cell-therapies |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated